- Home
- WK vs ZLAB Comparison
WK vs ZLAB Comparison
Compare WK & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WK
- ZLAB
- Stock Information
- Founded
- WK 2008
- ZLAB 2013
- Country
- WK United States
- ZLAB China
- Employees
- WK N/A
- ZLAB N/A
- Industry
- WK Computer Software: Prepackaged Software
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- WK Technology
- ZLAB Health Care
- Exchange
- WK Nasdaq
- ZLAB Nasdaq
- Market Cap
- WK 3.7B
- ZLAB 4.0B
- IPO Year
- WK 2014
- ZLAB 2017
- Fundamental
- Price
- WK $80.04
- ZLAB $35.04
- Analyst Decision
- WK Strong Buy
- ZLAB Buy
- Analyst Count
- WK 9
- ZLAB 6
- Target Price
- WK $102.56
- ZLAB $57.22
- AVG Volume (30 Days)
- WK 942.6K
- ZLAB 644.9K
- Earning Date
- WK 07-31-2025
- ZLAB 08-07-2025
- Dividend Yield
- WK N/A
- ZLAB N/A
- EPS Growth
- WK N/A
- ZLAB N/A
- EPS
- WK N/A
- ZLAB N/A
- Revenue
- WK $806,977,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- WK $20.80
- ZLAB $45.16
- Revenue Next Year
- WK $16.10
- ZLAB $56.81
- P/E Ratio
- WK N/A
- ZLAB N/A
- Revenue Growth
- WK 19.02
- ZLAB 32.56
- 52 Week Low
- WK $60.50
- ZLAB $17.30
- 52 Week High
- WK $116.83
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- WK 62.78
- ZLAB 47.54
- Support Level
- WK $75.23
- ZLAB $33.31
- Resistance Level
- WK $78.00
- ZLAB $36.77
- Average True Range (ATR)
- WK 2.85
- ZLAB 1.02
- MACD
- WK 0.26
- ZLAB -0.24
- Stochastic Oscillator
- WK 69.27
- ZLAB 28.90
About WK Workiva Inc.
Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.